Valuation: Nestmedic S.A.

Market Cap 35.08M 9.02M 8.03M 7.44M 6.74M 12.67M 855M 12.88M 89.29M 447M 33.84M 33.13M 1.43B P/E 2024
-2.96x
P/E 2025 -5.75x
Enterprise Value 35.91M 9.23M 8.22M 7.62M 6.9M 12.97M 875M 13.19M 91.4M 458M 34.64M 33.92M 1.46B EV / Sales 2024
22.3x
EV / Sales 2025 36.1x
Free-Float
45.56%
Yield 2024 *
-
Yield 2025 -
1 day-0.31%
1 week-7.31%
Current month-8.12%
1 month+26.80%
3 months-11.45%
6 months-8.65%
Current year-8.12%
1 week 0.6
Extreme 0.6
0.68
1 month 0.5
Extreme 0.5
0.72
Current year 0.49
Extreme 0.49
0.86
1 year 0.49
Extreme 0.49
0.88
3 years 0.39
Extreme 0.39
1.44
5 years 0.39
Extreme 0.39
2.9
10 years 0.39
Extreme 0.39
17.99
Manager TitleAgeSince
Chief Executive Officer - -
Chief Administrative Officer - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member 35 2019-07-14
Director/Board Member 55 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%-7.31%-24.07%-52.33% 9.02M
+1.18%+3.67%+26.39%+48.03% 254B
-0.08%+0.63%+7.61%+8.94% 158B
+1.11%+3.78%-4.46%+64.10% 155B
+1.18%+5.24%-54.66%-8.93% 66.06B
+0.59%+5.65%+11.46%+59.02% 51.6B
-1.00%+2.40%-15.58%-12.65% 51.82B
+1.23%+3.54%+17.27%+27.07% 50.89B
+1.83%+0.82%+20.99%+58.39% 48.78B
+1.97%+3.18%+29.04%+74.59% 43.51B
Average +0.03%+1.77%+1.40%+26.62% 87.92B
Weighted average by Cap. -0.44%+2.40%+7.46%+37.31%

Financials

2024 2025
Net sales 969K 249K 222K 206K 186K 350K 23.61M 356K 2.47M 12.36M 935K 916K 39.42M 846K 218K 194K 180K 163K 306K 20.62M 311K 2.15M 10.79M 816K 799K 34.42M
Net income -5.38M -1.38M -1.23M -1.14M -1.03M -1.94M -131M -1.98M -13.7M -68.59M -5.19M -5.08M -219M -4.6M -1.18M -1.05M -976K -884K -1.66M -112M -1.69M -11.71M -58.63M -4.44M -4.34M -187M
Net Debt 4.11M 1.06M 940K 871K 789K 1.48M 100M 1.51M 10.45M 52.34M 3.96M 3.88M 167M 830K 213K 190K 176K 159K 300K 20.21M 305K 2.11M 10.58M 800K 784K 33.74M
Projected Income Statement - Annual - Nestmedic S.A.
Logo Nestmedic S.A.
Nestmedic SA is a Poland-based company engaged in the manufacture of medical diagnostic equipment. The Company focuses on the development and production of a telemedicine cardiotocography (CTG) device for fetal health monitoring, named Pregnabit. The Pregnabit solution comprises the display device; fetal heart rate (FHR) probe; wrist heart rate monitor, which measures mother’s pulse; tocodynamometer (toco) probe, which measures contractions of the uterus, as well as fetal movement marker. Pregnabit enables pregnant women to take CTG tests at home, without specialist's assistance. The results are sent wirelessly to Medical Telemonitoring Center (MTC) where medical consultant analyzes data and provides medical opinion.
Employees
-
Date Price Change Volume
26-10-21 PLN 0.6340 -0.31% 60
26-10-20 PLN 0.6340 -0.31% 11,234
26-10-19 PLN 0.6360 -5.07% 38,347
26-10-16 PLN 0.6700 0.00% 2,611
26-10-15 PLN 0.6700 -2.05% 12,056